At DEVA İlaç San. ve Tic. A.Ş., monitoring the safety of our medicines and protecting patient safety are among our highest priorities.

Reporting potential adverse events that may occur during the use of medicines is of great importance for evaluating drug safety and taking necessary measures.

If you believe that any adverse event (adverse reaction) has occurred during the use of DEVA products, you may submit a report.

Adverse event reports may be submitted by healthcare professionals, patients, or their relatives.

How to Report an Adverse Event?

Adverse event / adverse reaction reports related to DEVA İlaç San. ve Tic. A.Ş. products can be submitted through one of the following methods:

1. Reporting via the TUFAM Adverse Event Reporting Form

You may submit your adverse event report using the TUFAM Adverse Event Reporting Form prepared by the Turkish Medicines and Medical Devices Agency (TİTCK).

📄 Click here to download the TUFAM Adverse Event Reporting Form.

After completing the form, you may send it to the following e-mail address:

E-mail: deva.pv@pleksus.com.tr

2. Reporting by Phone

You may also report an adverse event by phone.

📞 Phone: +90 212 692 92 92

To report an adverse event by phone, please press 5 during the call to reach the pharmacovigilance unit.

About Pharmacovigilance

Pharmacovigilance includes activities aimed at the detection, assessment, understanding, and prevention of adverse reactions and other safety-related issues associated with the use of medicinal products.

DEVA İlaç San. ve Tic. A.Ş. carries out the necessary processes for monitoring and evaluating drug safety in accordance with the applicable pharmacovigilance legislation and cooperates with relevant national and international health authorities.

Adverse event reports are an important source of information that contributes to the continuous monitoring of medicine safety.

Personal Data Protection Notice

Information shared within the scope of adverse event reporting is processed in accordance with the Law on the Protection of Personal Data No. 6698 (KVKK) and the relevant legislation.

Personal data submitted during an adverse event report may be processed for the following purposes:

  • Monitoring the safety of medicinal products

  • Evaluating adverse reactions

  • Fulfilling pharmacovigilance obligations

  • Reporting to competent health authorities

The information shared within this scope may be transferred to the Turkish Medicines and Medical Devices Agency (TİTCK) and, where required, to other relevant competent health authorities in accordance with legal requirements.

Personal data are processed solely for the purpose of carrying out pharmacovigilance activities, and the necessary technical and administrative measures are taken to ensure data security.

Within the scope of KVKK, data subjects may submit their requests regarding the processing of their personal data to info@deva.com.tr